Shift towards pro-inflammatory intestinal bacteria aggravates acute murine colitis via toll-like receptors 2 and 4

PLoS ONE

Volumn 2, Issue 7, 2007, Pages

  Heimesaat, Markus M ^a   Fischer, André ^a   Siegmund, Britta ^a   Kupz, Andreas ^a   Niebergall, Julia ^a   Fuchs, David ^a   Jahn, Hannah Katharina ^a   Freudenberg, Marina ^b   Loddenkemper, Christoph ^a   Batra, Arvind ^a   Lehr, Hans Anton ^c   Liesenfeld, Oliver ^a   Blaut, Michael ^d   Göbel, Ulf B ^a   Schumann, Ralf R ^a   Bereswill, Stefan ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE OF IMMUNOBIOLOGY AND EPIGENETICS   (Germany)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^d GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DEXTRAN; GAMMA INTERFERON; SODIUM SULFATE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR FOXP3; TLR2 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDES; CLOSTRIDIUM; COLITIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENTEROBACTERIACEAE; ENTEROCOCCUS; GENOTYPE; GRAM NEGATIVE BACTERIUM; IMMUNOHISTOCHEMISTRY; INTESTINE FLORA; LACTOBACILLUS; MESENTERY LYMPH NODE; MOUSE; NEUTROPHIL; NONHUMAN; PREVOTELLA; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; WILD TYPE; ANIMAL; BACTERIAL INFECTION; C57BL MOUSE; COLON; ENTERITIS; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; MICROBIOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; MURINAE; MUS; NEGIBACTERIA; PREVOTELLA;

ACUTE DISEASE; ANIMALS; BACTERIAL INFECTIONS; COLITIS; COLON; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; MICE; MICE, INBRED C57BL; NEUTROPHILS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 38649129512     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000662     Document Type: Article

References (34)

1. Podolsky DK (2002) Inflammatory bowel disease. N Engl Med 347: 417-429.
2. Basset C, Holton J (2002) Inflammatory bowel disease: is the intestine a Trojan horse? Sci Prog 85: 33-56.
3. Lodes MJ, Cong Y, Elson CO, Mohamath R, Landers CJ, et al. (2004) Bacterial flagellin is a dominant antigen in Crohn's disease. J Clin Invest 113: 1296-1306.
4. Swidsinski A, Ladhoff A, Pernthaler A, Swidsinski S, Loening-Baucke V, et al. (2002) Mucosal flora in inflammatory bowel disease. Gastroenterology 122: 44-54.
5. Swidsinski A, Weber J, Loening-Baucke V, Hale P, Lochs H (2005) Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease. J Clin Microbiol 43: 3380-3389.
6. Darfeuille-Michaud A, Boudeau J, Bulois P, Neut C, Glasser AL, et al. (2004) High prevalence of adherent-invasive Escherichia coli associated with ileal mucasa. in Crohn's disease. Gastroenterology 127: 412-421.
7. Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW (1999) Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term Follow-up of an open-label prospective randomized trial. Blood 93: 3267-3275.
8. Heimesaat MM, Bereswill S, Fischer A, Fuchs D, Struck D, et al. (2006) Grain-negative bacteria aggravate murine small intestinal Thl-type immunopathology following peroral infection with Toxoplasma gondii. J Immunol 177: 8785-8795.
9. Strober W, Fall IJ, Blumberg RS (2002) The immunology of mucosal models of inflammation. Ann Rev Immunol 20: 495-549.
10. Pizarro TT, Arseneau KO, Bamias G, Cominelli F (2003) Mouse models for the study of Crohn's disease. Trends Mol Med 9: 218-222.
11. Ortega-Cava CF, Ishihara S, Rumi MA, Kawashima K, Ishimura N, et al. (2003) Strategic compartmentalization of Toll-like recep. in the mouse gut. J Immunol 170: 3977-3985.
12. Hart AL, Al-Hassi HO, Rigby RJ, Ben SJ, Emmanuel AV, et al. (2005) Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129: 50-65.
13. Cario E, Podolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68: 7010-7017.
14. Heimesaat MM, Fischer A, Jahn RK, Niebergall J, Freudenberg M, et al. (2007) Exacerbation of marine ileitis by toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56: 941-948.
15. Tlaskalova-Hogenova HL, Tuckova R, Stepankova T, Hudcovic T, Palová-Jeln̂ková L, et al. (2005) Involvement of innate immunity in the development of inflammatory and autoimmune diseases. Ann NY Acad Sci 1051: 787-798.
16. Lange S, Delbro DS, Jennische E, Mattsby-Baltzer I (1996) The role of the Lps gene in experimental ulcerative colitis in mice. APMIS 104: 823-833.
17. Stevceva L, Pavli P, Buffinton G, Wozniak A, Doe WF (1999) Dextran sodium sulphate-induced colitis activity varies with mouse strain but develops in lipopolysaccharide-unresponsive mice. J Gastroenterol Heatol 14: 54-60.
18. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R (2004) Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
19. Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, et al. (2005) My88-deficient mire develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 40: 16-23.
20. Fukata M, Michelsen KS, Eri R, Thomas LS, Hu B et al. (2005) Tollt-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am J Physiol Gastrointest Liver Physiol 288: G1055-1065.
21. Fukata M, Chen A, Klepper S, Krishnareddy S, Vamadevan AS, et al. (2006) Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 131: 862-877.
22. Rakoff-Nahoum S, Hao L, Medzhitov R (2006) Role or toll-like receptors in spontaneous commensal-dependent colitis Immunity 25: 319-329.
23. Vowinkel T, Anthoni C, Wood KC, Stokes KY, Russell J, et al. (2007) CD40-CD40 ligand mediates the rěcruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology 132: 955-965.
24. Maul J, Loddenkemper C, Mundt P, Berg E, Giese T, et al. (2GO5) Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. Gastroenterology 128: 1868-1878.
25. Hisebye E (2005) The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy 51 (Suppl. 1): 1-22.
26. Schuppler M, Lotzsch Y, Waidmann M, Autenrieth IB (2004) An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect Immun 72: 1983-1990.
27. Ruiz PA, Shkoda A, Kim SC, Sartor RB, Haller D (2005) IL-10 gene-deficient mice lack TGF-beta/Smad signaling and fail to inhibit proinflammatory gene expression in intestinal epithelial cells after the colonization with colitogenic Enterococcus faecalis. J Immunol 174: 2990-2999.
28. Kim SC, Tonkonogy SL, Albright CA, Tsang J, Halish EJ, et al. (2005) Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128: 891-906.
29. Waidmann M, Bechtold O, Frick JS, Lehr RA, Schubert S, et al. (2003) Bacteroides vulgalus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125: 162-177.
30. Hans W, Schölmerick J, Gross V, Falk W (2000) The role or the resident intestinal flora in acute ano chronic dextran sulfate sodium-induced colitis in mice. Eur J Gastroenterol Hepatol 12: 267-273.
31. Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, et al. (2001) Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice. Infect Immun 69: 2277-2285.
32. Fort MM, Mozaffarian A, Slover AG, Correia Jda S, Johnson DA, et al. (2005) A synthetic TLR4 antagonist hag anti-inflammatory effects in two murine models of inflammatory bowel disease. J Immumol 174: 6416-6423.
33. Siegmund B, Rieder F, Albrich S, Wolf K, Bidlingmaier C, et al. (2001) Adenosine kinase inhibitor GP315 improves experimental colitis in mice. J Pharmacol Exp Ther 296: 99-105,
34. Aebischer T, Fischer A, Walduck A, Schlötelburg C, Lindig M, et al. (2006) Vaccination prevents Helicobacter pylori induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol 46: 221-229.